Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to non-human primates.

被引:1
|
作者
Neville, K
Parise, RA
Blaney, SM
Thompson, P
Aleksic, A
Egorin, MJ
Balis, FM
McGuffey, L
McCully, C
Berg, SL
机构
[1] Indiana Univ, Indianapolis, IN 46204 USA
[2] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA
[3] Baylor Coll Med, Houston, TX 77030 USA
[4] NCI, Bethesda, MD 20892 USA
关键词
D O I
10.1016/j.clpt.2003.11.223
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:P59 / P59
页数:1
相关论文
共 50 条
  • [1] The plasma and cerebrospinal fluid pharmacokinetics of satraplatin after intravenous administration in non-human primates
    Marcus, Leigh J.
    Murphy, Robert F.
    Fox, Elizabeth
    McCully, Cynthia L.
    Cruz, Rafeal
    Warren, Kathy
    Balis, Frank M.
    Widemann, Brigitte C.
    Meyer, Thorsten
    [J]. CANCER RESEARCH, 2010, 70
  • [2] The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates
    AeRang Kim
    Cindy McCully
    Rafael Cruz
    Diane E. Cole
    Elizabeth Fox
    Frank M. Balis
    Brigitte C. Widemann
    [J]. Investigational New Drugs, 2012, 30 : 524 - 528
  • [3] Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates
    Stacie L. Stapleton
    Joel M. Reid
    Patrick A. Thompson
    Matthew M. Ames
    Renee M. McGovern
    Leticia McGuffey
    Jed Nuchtern
    Robert Dauser
    Susan M. Blaney
    [J]. Cancer Chemotherapy and Pharmacology, 2007, 59 : 461 - 466
  • [4] Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates
    Stapleton, Stacie L.
    Reid, Joel M.
    Thompson, Patrick A.
    Ames, Matthew M.
    McGovern, Renee M.
    McGuffey, Leticia
    Nuchtern, Jed
    Dauser, Robert
    Blaney, Susan M.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (04) : 461 - 466
  • [5] The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates
    Kim, AeRang
    McCully, Cindy
    Cruz, Rafael
    Cole, Diane E.
    Fox, Elizabeth
    Balis, Frank M.
    Widemann, Brigitte C.
    [J]. INVESTIGATIONAL NEW DRUGS, 2012, 30 (02) : 524 - 528
  • [6] Plasma and cerebrospinal fluid pharmacokinetics of valproic acid after oral administration in non-human primates
    Stapleton, Stacie L.
    Thompson, Patrick A.
    Ou, Ching-Nan
    Berg, Stacey L.
    McGuffey, Leticia
    Gibson, Brian
    Blaney, Susan M.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (04) : 647 - 652
  • [7] Plasma and cerebrospinal fluid pharmacokinetics of valproic acid after oral administration in non-human primates
    Stacie L. Stapleton
    Patrick A. Thompson
    Ching-Nan Ou
    Stacey L. Berg
    Leticia McGuffey
    Brian Gibson
    Susan M. Blaney
    [J]. Cancer Chemotherapy and Pharmacology, 2008, 61 : 647 - 652
  • [8] Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primates
    Neville, K
    Parise, RA
    Thompson, P
    Aleksic, A
    Egorin, MJ
    Balis, FM
    McGuffey, L
    McCully, C
    Berg, SL
    Blaney, SM
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (07) : 2525 - 2529
  • [9] Plasma and cerebrospinal fluid pharmacokinetics of ABT-888 after oral administration in non-human primates
    Jodi A. Muscal
    Patrick A. Thompson
    Vincent L. Giranda
    Brian D. Dayton
    Joy Bauch
    Terzah Horton
    Leticia McGuffey
    Jed G. Nuchtern
    Robert C. Dauser
    Brian W. Gibson
    Susan M. Blaney
    Jack M. Su
    [J]. Cancer Chemotherapy and Pharmacology, 2010, 65 : 419 - 425
  • [10] Plasma and cerebrospinal fluid pharmacokinetics of ABT-888 after oral administration in non-human primates
    Muscal, Jodi A.
    Thompson, Patrick A.
    Giranda, Vincent L.
    Dayton, Brian D.
    Bauch, Joy
    Horton, Terzah
    McGuffey, Leticia
    Nuchtern, Jed G.
    Dauser, Robert C.
    Gibson, Brian W.
    Blaney, Susan M.
    Su, Jack M.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (03) : 419 - 425